Antimicrobial plastics are used in a variety of consumer and medical products such as kitchen appliances, food processing equipment, medical devices, and healthcare facilities. These plastics help prevent the growth of microbes like bacteria, viruses, mold and mildew on plastic surfaces. The growing focus on hygiene and infection control in the healthcare sector as well as daily consumer products has majorly driven the demand for antimicrobial plastics. The global antimicrobial plastics Market is estimated to be valued at US$ 32.42 Bn in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

Rising health awareness among consumers has led to higher demand for hygienic products that inhibit microbial growth. Antimicrobial plastics help maintain the hygiene of frequently used surfaces and prolong the life of materials by preventing degradation from microbes. This has significantly boosted their adoption in end-use industries like healthcare, packaging, food and beverages, and consumer goods. Another key driver fueling the antimicrobial plastics market is the COVID-19 pandemic that has heightened focus on cleanliness and disinfection. Stringent regulations regarding use of antimicrobial components in medical devices and increasing investments by governments worldwide for improving health infrastructure will further support market expansion over the forecast period.

SWOT Analysis

Strength: Antimicrobial plastics have three main strengths. Firstly, they help prevent microbial contamination and growth which helps increase the shelf life of products. Secondly, they improve hygiene and sanitation as microbes cannot survive on these plastics. Thirdly, they reduce healthcare costs in the long run as use of antimicrobial plastics can minimize infectious diseases.

Weakness: Two main weaknesses are their higher costs compared to regular plastics and certain regulatory issues. As antimicrobial additives are added, plastic production becomes more expensive. Also, more regulatory approvals are needed before these plastics can be used in medical and food applications.

Opportunity: The food packaging and medical devices industries offer two big opportunities. Growing health awareness is increasing demand for hygienic and contamination-free food packaging. Also, prevalence of hospital-acquired infections makes antimicrobial plastics relevant for medical devices.

Threats: Substitution threat from other hygienic materials and stricter regulations for antimicrobial claims are two threats. New advanced materials may replace plastics for certain uses. Also, overstating antimicrobial properties can attract regulatory penalties.

Key Takeaways

The Global Antimicrobial Plastics Market Size is expected to witness high growth. The market size for 2023 is estimated at US$ 32.42 billion and projected to rise at a CAGR of 5.6% during the forecast period of 2023 to 2030. Regional analysis North America dominates currently due to stringent hygiene and regulatory standards. Growth is fastest in Asia Pacific due to increasing healthcare expenditures, rising living standards and expanding medical device industry.

Key players operating in the Antimicrobial Plastics are Pfizer Inc., Abbott Laboratories, AstraZeneca Plc., Novartis AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Sanofi S.A., Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc.

Get More Insights Here

https://www.trendingwebwire.com/antimicrobial-plastics-market-share-size-forecast-outlook-2023-2030/